Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-30 Option Award | 2024-07-17 4:59 pm | N/A 2034-04-30 | PharmaCyte Biotech Inc. | PMCB | WEINSTEIN ROBERT Director | 38,009 | $0 | 38,009 (Direct) | View |
2024-04-30 Option Award | 2024-07-17 4:58 pm | N/A 2034-04-30 | PharmaCyte Biotech Inc. | PMCB | WALKER WAYNE REMELL Director | 38,009 | $0 | 38,009 (Direct) | View |
2024-04-30 Option Award | 2024-07-17 4:58 pm | N/A 2034-04-30 | PharmaCyte Biotech Inc. | PMCB | SCHECHTER JONATHAN Director | 38,009 | $0 | 38,009 (Direct) | View |
2024-04-30 Option Award | 2024-07-17 4:58 pm | N/A 2034-04-30 | PharmaCyte Biotech Inc. | PMCB | Abecassis Michael M Director | 38,009 | $0 | 38,009 (Direct) | View |
Ownership | 2024-05-30 4:05 pm | 2024-05-23 N/A | MyMD Pharmaceuticals Inc. | MYMD | PharmaCyte Biotech Inc. 10% Owner | 0 | $0 | 11,563,878 (Direct) | View |
Ownership | 2023-11-28 5:06 pm | 2023-11-21 2025-11-21 | FEMASYS INC | FEMY | PharmaCyte Biotech Inc. 10% Owner | 0 | $0 | 12,711,864 (Direct) | View |
2023-11-20 Option Award | 2023-11-22 5:02 pm | 2023-11-20 2033-11-20 | PharmaCyte Biotech Inc. | PMCB | WEINSTEIN ROBERT Director | 61,248 | $0 | 61,248 (Direct) | View |
2023-11-20 Option Award | 2023-11-22 5:02 pm | 2023-11-20 2033-11-20 | PharmaCyte Biotech Inc. | PMCB | WALKER WAYNE REMELL Director | 61,248 | $0 | 61,248 (Direct) | View |
2023-11-20 Option Award | 2023-11-22 5:01 pm | N/A 2033-11-20 | PharmaCyte Biotech Inc. | PMCB | Trujillo Carlos Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |
2023-11-20 Option Award | 2023-11-22 5:01 pm | N/A 2033-11-20 | PharmaCyte Biotech Inc. | PMCB | Silverman Joshua Interim CEO, Interim President | 170,000 | $0 | 170,000 (Direct) | View |
2023-11-20 Option Award | 2023-11-22 5:01 pm | 2023-11-20 2033-11-20 | PharmaCyte Biotech Inc. | PMCB | SCHECHTER JONATHAN Director | 61,248 | $0 | 61,248 (Direct) | View |
2023-11-20 Option Award | 2023-11-22 5:00 pm | 2023-11-20 2033-11-20 | PharmaCyte Biotech Inc. | PMCB | Abecassis Michael M Director | 61,248 | $0 | 61,248 (Direct) | View |
2022-12-28 Option Award | 2022-12-30 4:05 pm | 2022-12-28 2032-11-14 | PharmaCyte Biotech Inc. | PMCB | Farb Daniel Stuart Director | 125,000 | $0 | 125,000 (Direct) | View |
2022-12-28 Option Award | 2022-12-30 4:05 pm | 2022-12-28 2032-11-14 | PharmaCyte Biotech Inc. | PMCB | Allen Daniel Director | 125,000 | $0 | 125,000 (Direct) | View |
Ownership | 2022-08-24 08:19 am | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Allen Daniel Director | 0 | $0 | 260,000 (Indirect) | View |
Ownership | 2022-08-23 9:48 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | SCHECHTER JONATHAN Director | 0 | $0 | 50,000 (Direct) | View |
Ownership | 2022-08-23 5:50 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Silverman Joshua Director | 0 | $0 | 50,000 (Indirect) | View |
Ownership | 2022-08-23 06:02 am | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Farb Daniel Stuart Director | 0 | $0 | 1,509,570 (Indirect) | View |
Ownership | 2022-04-11 09:00 am | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Loehr Matthias Director | 0 | $0 | 3,004 (Indirect) | View |
Ownership | 2021-09-03 7:19 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Trujillo Carlos CFO | 0 | $0 | 18,800 (Direct) | View |
Ownership | 2021-08-31 6:25 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Waggoner Kenneth L. Chairman, CEO, Pres and GC | 0 | $0 | 35,600 (Direct) | View |
Ownership | 2021-08-31 6:24 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | YUEN THOMAS C K Director | 0 | $0 | 3,337 (Direct) | View |
Ownership | 2021-08-31 6:23 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Crabtree Gerald W Chief Science Officer | 0 | $0 | 16,200 (Direct) | View |
Ownership | 2021-08-20 8:36 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Liquard Thomas Director | 0 | $0 | 3,337 (Direct) | View |
Ownership | 2021-08-20 8:36 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Tong Raymond CF Director | 0 | $0 | 2,669 (Direct) | View |
Ownership | 2021-08-20 8:35 pm | N/A N/A | PharmaCyte Biotech Inc. | PMCB | Abecassis Michael M Director | 0 | $0 | 4,937 (Direct) | View |